Oncology Institute, Inc.
Provides comprehensive, value-based cancer care in community settings.
TOI | US
Overview
Corporate Details
- ISIN(s):
- US23343Q2093 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 18000 STUDEBAKER RD, 90703 CERRITOS
- Industry:
- Medical and dental practice activities
Description
Oncology Institute, Inc. is a specialized oncology company that provides comprehensive, value-based cancer care within community settings. Operating a network of clinics and affiliate locations, the company focuses on delivering evidence-based medical oncology services. Its treatment offerings encompass a full spectrum of therapies, including high-precision radiation, chemotherapy, immunotherapy, targeted therapy, and hormone therapy. The institute's model emphasizes personalized, patient-centered care through its High-Value Cancer Care (HVCC) program, which addresses medical, emotional, and social needs. In addition to standard treatments, the company facilitates patient access to clinical trials for emerging therapies. The core mission is to enhance patient outcomes by providing advanced cancer care in convenient, local environments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Oncology Institute, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oncology Institute, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oncology Institute, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||